April 30, 2025
Press Release oomnia CTMS oomnia eCOA oomnia eConsent oomnia EDC oomnia ePRO oomnia eSource oomnia eTMF oomnia RTSM Clinical data management Biostatistics and programming Trial design and medical writing Large biopharma Emerging biopharma CROs Academia Clinical trial units MedTech Food industry Nutraceuticals Cosmetics Animal health Oncology Rare diseases Cardiovascular Neurology / CNS Infectious diseases Immunology Respiratory Dermatology Endocrinology Gastroenterology Ophthalmology

Wemedoo in The CEO Magazine: Fixing Clinical Trials

We’re proud to be featured in The CEO Magazine Global, where we share our vision for transforming the clinical research landscape.

Today’s trials are still slowed down by fragmented systems, outdated workflows, and manual processes that slow progress and increase costs. At Wemedoo, we believe it doesn’t have to be this way.

Our solution? oomnia, a unified clinical software platform built to simplify, accelerate, and modernize the entire trial lifecycle. With oomnia, we are not just optimizing trials, we're reimagining how clinical research is done.

Read the full article in The CEO Magazine Global